ROWLAND LLOYD A 4
4 · CytomX Therapeutics, Inc. · Filed Dec 22, 2023
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Sale
Common Stock
2023-12-20$1.38/sh−4,077$5,629→ 97,996 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
- [F2]Includes 41,875 restricted stock units.